Skip to content

Clinical trials

Pleural Effusion, Malignant trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pleural Effusion, Malignant Country / region: China Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20092
20111
20121
20131
20141
20152
20162
20181
20202
20212
20223
20233
20242
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status13
Recruiting6
Not yet recruiting5
Completed4
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jemincare2
Jiangsu Simcere Pharmaceutical Co., Ltd.2
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology2
Affiliated Hospital of Jiangnan University1
Amgen1
Base Therapeutics (Shanghai) Co., Ltd.1
Chinese PLA General Hospital1
Gang Hou1
Guizhou Medical University1
Haihong Yang, MD, Pricipal investigator1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pleural Effusion, Malignant30
Carcinoma, Non-Small-Cell Lung7
Lung Neoplasms2
Pleural Effusion2
Anemia1
Ascites1
Disease1
Empyema1
Mesothelioma, Malignant1
Neoplasm Metastasis1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.